Incyte today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an ...
The application opens Dec. 1, 2025 for the 2026-27 school year. Most applications are due between Feb. 15 and March 15. Prospective students will have access after applying for admission. View more ...
About the role In every corner of the UK, 400,000 participants are limbering up to join the fight against cancer. Last year, our Race for Life events raised an incredible £26 million, which will help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback